Bridges Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-1,700
| Closed | -$505K | – | 219 |
|
2019
Q4 | $505K | Sell |
1,700
-4,870
| -74% | -$1.45M | 0.02% | 194 |
|
2019
Q3 | $1.53M | Sell |
6,570
-5,599
| -46% | -$1.3M | 0.06% | 156 |
|
2019
Q2 | $2.85M | Sell |
12,169
-22,169
| -65% | -$5.18M | 0.11% | 106 |
|
2019
Q1 | $8.12M | Sell |
34,338
-913
| -3% | -$216K | 0.33% | 70 |
|
2018
Q4 | $10.6M | Buy |
35,251
+9,654
| +38% | +$2.91M | 0.5% | 45 |
|
2018
Q3 | $9.04M | Buy |
25,597
+2,562
| +11% | +$905K | 0.45% | 56 |
|
2018
Q2 | $6.69M | Buy |
23,035
+974
| +4% | +$283K | 0.3% | 72 |
|
2018
Q1 | $6.04M | Buy |
22,061
+7,344
| +50% | +$2.01M | 0.28% | 74 |
|
2017
Q4 | $4.69M | Sell |
14,717
-1,525
| -9% | -$486K | 0.38% | 60 |
|
2017
Q3 | $5.09M | Buy |
16,242
+3,932
| +32% | +$1.23M | 0.48% | 52 |
|
2017
Q2 | $3.34M | Sell |
12,310
-925
| -7% | -$251K | 0.45% | 52 |
|
2017
Q1 | $3.62M | Sell |
13,235
-803
| -6% | -$220K | 0.5% | 50 |
|
2016
Q4 | $3.98M | Sell |
14,038
-1,400
| -9% | -$397K | 0.56% | 44 |
|
2016
Q3 | $4.83M | Sell |
15,438
-275
| -2% | -$86.1K | 0.81% | 38 |
|
2016
Q2 | $3.8M | Buy |
15,713
+265
| +2% | +$64.1K | 0.66% | 43 |
|
2016
Q1 | $4.02M | Buy |
15,448
+1,225
| +9% | +$319K | 0.73% | 40 |
|
2015
Q4 | $4.36M | Buy |
14,223
+2,458
| +21% | +$753K | 0.78% | 35 |
|
2015
Q3 | $4.75M | Hold |
11,765
| – | – | 0.82% | 33 |
|
2015
Q2 | $4.75M | Buy |
11,765
+2,605
| +28% | +$1.05M | 0.82% | 33 |
|
2015
Q1 | $3.87M | Buy |
9,160
+1,680
| +22% | +$709K | 0.68% | 36 |
|
2014
Q4 | $2.54M | Buy |
7,480
+2,637
| +54% | +$895K | 0.45% | 53 |
|
2014
Q3 | $1.6M | Hold |
4,843
| – | – | 0.3% | 67 |
|
2014
Q2 | $1.53M | Buy |
4,843
+335
| +7% | +$106K | 0.29% | 68 |
|
2014
Q1 | $1.38M | Buy |
4,508
+658
| +17% | +$201K | 0.29% | 65 |
|
2013
Q4 | $1.08M | Buy |
3,850
+25
| +0.7% | +$6.99K | 0.24% | 72 |
|
2013
Q3 | $921K | Buy |
3,825
+200
| +6% | +$48.2K | 0.23% | 74 |
|
2013
Q2 | $780K | Buy |
+3,625
| New | +$780K | 0.21% | 77 |
|